Mortality in patients with familial adenomatous polyposis.
about
Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosisRisk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysisThe development of duodenal microadenomas in FAP patients: the human correlate of the Min mouseImaging features of superficial and deep fibromatoses in the adult population.Application of a spontaneously closed protective stoma in an ileal pouch-anal anastomosis: a preliminary study.Lower gastrointestinal tract cancer predisposition syndromesDesmoid tumour biology in patients with familial adenomatous polyposis coli.Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.Iatrogenic pancreatitis in familial adenomatous polyposisClinical characteristics and adequate treatment of familial adenomatous polyposis combined with desmoid tumors.Adrenocortical Secreting Mass in a Patient with Gardner's Syndrome: A Case ReportEvaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.Identification of patients at risk for hereditary colorectal cancerProgression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technologyDecision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients.Results of national registration of familial adenomatous polyposis.Duodenal adenomatosis in familial adenomatous polyposis.Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation.Endoscopic management of nonampullary duodenal polyps.Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis.Familial adenomatous polyposis: challenges and pitfalls of surgical treatment.Primary duodenal carcinoma.Clinicopathological features of familial adenomatous polyposis in Korean patients.Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.Desmoid Tumours in Familial Adenomatous Polyposis: Review of 17 Patients from a Portuguese Tertiary Center.Clinicopathologic characteristics associated with complications and long-term outcomes of endoscopic papillectomy for adenoma.Surgical management of the duodenal manifestations of familial adenomatous polyposis.Diagnosis and management of ampullary adenoma: The expanding role of endoscopy.Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.Gastric tumours in FAP.Dispelling misconceptions in the management of familial adenomatous polyposis.Prognostic impact of hospital volume on familial adenomatous polyposis: a nationwide multicenter study.Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution.Mesenteric Fibromatosis in Crohn's Disease as a Potential Effect of Adalimumab.Family history of cancer.Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis.Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis.Desmoid Tumors: A Clear Perspective or a Persisting Enigma? A Case Report and Review of Literature.
P2860
Q28260527-1751BCDE-ABF4-46B0-B851-D82D9D134E2DQ28284463-5B33DF35-6F38-48F3-93E0-9C570001F1E1Q28507304-A0979543-5069-4870-B7B9-9068AFC3914CQ30463808-84088061-1C04-491A-9812-B280BB1A16D7Q33464475-3371D8FB-CC40-48AD-AA84-80E54C57FAE7Q33920573-758E0D9B-7972-4202-93D5-36B21C36CD78Q34035180-CCA3F734-00D6-445B-B6FF-061D17988AC3Q34154918-CEC82852-53C4-47A2-8323-78CDF204D80CQ34378109-EF5AE1FC-3512-42E0-A9D9-85B794698BC7Q34381290-71FD8CA2-F53C-4AE4-85C1-31F7E91B4FD9Q34386001-922D4BE5-56E7-4654-AD28-6704AA36348DQ34461251-0D18D585-E108-4650-B02F-C0D3754B97A4Q34577487-6178F9F4-85DB-4C03-AA87-EC72E6914D8BQ34652530-E99168EB-A649-4A9E-8D3B-661925D7F887Q35219163-D22F9C4E-D92F-4DD4-B41B-C138B9A30698Q35364431-D468A84D-2401-4C4B-8CAF-599DA5777F65Q35595570-EC477AFE-786A-4F15-9DA1-70A3249E581BQ35596339-480C61DE-B40A-404C-911F-ED3653786E0EQ35597084-D946D726-E728-45D1-9511-C492079D8A73Q35810195-2187B590-932C-4BF8-8510-B6475047EAAEQ35885813-30B9121A-312D-457C-9644-E179D874C69CQ36178250-29079A3F-B75C-4E30-8480-4462894CA639Q36680098-DBD1ACC7-4BC3-4FFF-8EB0-FBE6E850590BQ36859992-E793DC1F-25F3-4E74-BE01-99B6B97C39FAQ37020108-B6B178A6-0033-4071-BE62-945357B89463Q37382232-637763D3-A84D-435C-9D04-D520CDF8EEECQ37435583-997D7439-A745-4845-BE27-C518CBBF45D0Q37708272-A4FCE753-E026-46CB-A420-EC03A8E77B3FQ37886899-9C2EC61A-2B88-49EC-8ECB-475EB16F67A7Q37971029-DD4F471E-CE65-4897-A45E-08E7B1D25904Q38884242-5EB4D364-25B4-47AD-9E9B-81A823A6B2ACQ38921987-36BE37A8-EEB4-4DDE-831F-B3C00451C284Q39165144-7B4AF6EF-95AC-4990-8DD1-8A23840D79E5Q40083498-7FFF231A-D221-45D6-8D89-499034B62E28Q40531815-46479BC8-DF06-4A6E-BA22-2C33D0A458C0Q40567403-1A33DC9F-AE79-4F60-AE54-D4A43B1DAB7BQ40925436-D96528A8-BC37-4245-915A-999BFC0F40CEQ41019314-1A31ECB9-A878-48C3-9022-F13018ACDC89Q41598560-0756B860-5067-4DF3-99F4-F50EC5D0A7E1Q42286668-2E20C231-6E36-49FA-855E-DF94CB334BD4
P2860
Mortality in patients with familial adenomatous polyposis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mortality in patients with familial adenomatous polyposis.
@en
Mortality in patients with familial adenomatous polyposis.
@nl
type
label
Mortality in patients with familial adenomatous polyposis.
@en
Mortality in patients with familial adenomatous polyposis.
@nl
prefLabel
Mortality in patients with familial adenomatous polyposis.
@en
Mortality in patients with familial adenomatous polyposis.
@nl
P2093
P356
P1476
Mortality in patients with familial adenomatous polyposis.
@en
P2093
Arvanitis ML
Jagelman DG
McGannon E
P2888
P304
P356
10.1007/BF02150736
P577
1990-08-01T00:00:00Z